Accordingly, Lugli et al. [10] reported on a large set of 1420 cases that loss of MUC2 is associated with the presence of lymph node metastasis and with worse survival in both MMR-proficient and MMR-deficient tumors. The gene discussed is MRC1; the disease is metastatic malignant neoplasm in the lymph nodes.